TELOMERE / SENESCENT CELL TARGETING Epitalon - 100mg + FOX04 - DRI - 30mg  Epitalon + FOXO4-DRI is a research combination designed to explore two major biological pathways strongly associated with aging and cellular decline: telomere maintenance mechanisms and senescent cell signaling. Epitalon is widely studied for its potential involvement in telomerase-related pathways and circadian regulation, while FOXO4-DRI is a peptide of interest in senescence research due to its reported ability to interfere with FOXO4–p53 interactions in experimental models. This interaction has been associated with selective signaling effects in senescent cells, making FOXO4-DRI a key compound in research focused on senescent cell targeting and tissue homeostasis. Together, this combination is positioned for advanced research into mechanisms linked to cellular aging, tissue regeneration pathways, and biological resilience. According to experimental and preclinical research, this research set has been associated with the following areas of interest: Telomere biology and telomerase pathway research Senescent cell targeting and apoptosis-related signaling mechanisms Support of tissue homeostasis in aging models Investigation of cellular stress-response pathways Research into age-related functional decline at tissue and organ level Scientific interest in pathways related to immune regulation and systemic aging mechanisms All information provided above refers exclusively to laboratory, experimental, or preclinical research contexts and is intended for scientific and educational discussion only.

INDEPENDENTLY TESTED • VERIFIED QUALITY ✓ Purity — HPLC analysis ✓ Identity — Mass spectrometry ✓ Net content — Verified on the 6 mg vial RETA 6 mg and 10 mg share the same peptide batch. The tested sample was a 6 mg vial. VERIFY COA AT FREEDOM DIAGNOSTICS → Enter search code: Suaw2605040577Reta is a next-generation metabolic research peptide classified as a multi-receptor agonist designed to interact with GLP-related, GIP-associated, and glucagon-mediated signaling pathways. By targeting multiple receptor systems simultaneously, it has become a key subject of investigation in studies focused on integrative metabolic regulation, energy balance, and complex signaling networks. Its molecular structure has been engineered to enhance stability and albumin binding, supporting an extended activity profile and improved pharmacokinetic characteristics in research environments. Current research explores its role in multi-pathway signaling dynamics, systemic regulatory processes, and advanced metabolic communication mechanisms.

Research suggests that Retinalamin is of interest in ophthalmology and retinal-support research due to its potential role in supporting retinal tissue function, microcirculation, and recovery mechanisms under conditions of degeneration or vascular stress. Studies indicate that it may be relevant in a range of retinal and vision-related disorders, including diabetic retinopathy, myopic disease, retinitis pigmentosa, age-related macular degeneration (AMD), chorioretinitis, primary open-angle glaucoma, and other eye diseases associated with impaired retinal performance and progressive vision decline. FRESHLY PREPARED SOLUTION

Research suggests that Retinalamin is of interest in ophthalmology and retinal-support research due to its potential role in supporting retinal tissue function, microcirculation, and recovery mechanisms under conditions of degeneration or vascular stress. Studies indicate that it may be relevant in a range of retinal and vision-related disorders, including diabetic retinopathy, myopic disease, retinitis pigmentosa, age-related macular degeneration (AMD), chorioretinitis, primary open-angle glaucoma, and other eye diseases associated with impaired retinal performance and progressive vision decline.

RTD-1 is a macrocyclic θ-defensin peptide expressed in Old World monkeys and studied for its broad-spectrum antibacterial, antifungal, and antiviral activity. Research indicates it may function by interacting with microbial membranes while also exerting significant immunomodulatory effects. Notably, experimental studies in a rodent model of rheumatoid arthritis showed that RTD-1 rapidly suppressed and reversed autoimmune joint disease, improving mobility and preserving joint structure. Mechanistically, RTD-1 reduced joint IL-1β levels, inhibited IL-6 production, suppressed fibroblast-like synoviocyte invasiveness, and inhibited destructive proteases such as ADAM17/ADAM10, metalloproteases, and cathepsin K. These properties have positioned RTD-1 as a promising research peptide of interest in antimicrobial defense and inflammation-related disease models.

INDEPENDENTLY TESTED • VERIFIED QUALITY ✓ Purity — HPLC analysis ✓ Identity — Mass spectrometry ✓ Net content — Verified on the 5 mg vial SEMA 5 mg and 10 mg share the same peptide batch. The tested sample was a 5 mg vial. VERIFY COA AT FREEDOM DIAGNOSTICS → Enter search code: Suaw2605040573SEMA is a synthetic metabolic research peptide belonging to a class of regulatory compounds associated with incretin-related signaling pathways. It is widely studied for its interaction with receptor-mediated mechanisms involved in glucose handling, energy balance, and systemic metabolic regulation. Research interest also extends to its role in broader signaling networks, including those associated with cardiovascular function and neuroendocrine communication, making it a key compound in modern metabolic research models.

Sermorelin is a synthetic peptide derived from Growth Hormone-Releasing Hormone (GHRH) that stimulates the pituitary gland to increase endogenous growth hormone secretion. By activating GHRH receptors, Sermorelin promotes physiological GH release and enhances downstream IGF-1 production, supporting anabolic and regenerative signaling. Research suggests it may be relevant in studies involving body composition improvement, bone density support, metabolic regulation, and tissue repair. Additional research interest includes potential cardiovascular recovery effects through reduced scar remodeling, neuroprotective support via IGF-1-mediated neuronal resilience, and systemic benefits in chronic inflammation-related conditions. Due to its feedback-regulated mechanism and sustained receptor responsiveness, Sermorelin remains an important peptide in research related to endocrine aging, regeneration, and long-term metabolic health.

Setmelanotide is a synthetic peptide and potent melanocortin 4 receptor (MC4R) agonist studied for its ability to restore satiety signaling in rare genetic disorders such as POMC deficiency, PCSK1 deficiency, and leptin-related pathway dysfunction. It works by directly activating MC4R, bypassing upstream genetic defects that impair production of α-MSH and other satiety mediators. Research suggests that setmelanotide has significantly higher potency than endogenous α-MSH and may reduce hyperphagia and support weight loss in genetically defined obesity conditions. Its activity may be influenced by its atypical bitopic binding behavior, interacting with both orthosteric and putative allosteric receptor sites, potentially contributing to improved receptor specificity and a distinct signaling profile compared to earlier MC4R agonists.

SLU-PP-332 is a synthetic small-molecule research compound best known as a pan-agonist of ERRα, ERRβ, and ERRγ, a family of nuclear receptors involved in mitochondrial function, oxidative metabolism, and cellular energy regulation. Its main interest lies in its ability to shift tissues toward a more oxidative metabolic state. Rather than acting like a stimulant, it appears to influence upstream transcriptional programs that regulate how cells produce and use energy. This includes effects on mitochondrial biogenesis, fatty acid oxidation, oxidative phosphorylation, and overall fuel preference. In preclinical studies, SLU-PP-332 has been associated with increased mitochondrial respiration, enhanced oxidative muscle remodeling, greater reliance on fat oxidation, higher energy expenditure, and improved endurance-related parameters in animal models. It has also shown activity in experimental settings involving metabolic dysfunction, liver fat accumulation, cardiac energy impairment, and age-related mitochondrial decline. Overall, SLU-PP-332 is best described as a preclinical metabolic reprogramming compound with exercise-mimetic and oxidative metabolic activity. It is relevant for research into mitochondrial biology, fuel utilization, and ERR-driven transcriptional regulation.

SS-31 (Elamipretide) is a mitochondria-targeting peptide studied for its ability to bind cardiolipin in the inner mitochondrial membrane, stabilize mitochondrial structure, and support cellular energy production. Research suggests that SS-31 may reduce mitochondrial oxidative stress by limiting reactive oxygen species accumulation, improving mitochondrial bioenergetics, and supporting membrane integrity. It has also been investigated for its ability to modulate the mitochondrial permeability transition pore (mPTP), potentially reducing apoptosis-related signaling under stress. Due to these mechanisms, SS-31 has attracted attention in research involving neurodegenerative diseases, cardiovascular disorders, age-related mitochondrial decline, and retinal diseases such as diabetic retinopathy and age-related macular degeneration.

SS-31 (Elamipretide) is a mitochondria-targeting peptide studied for its ability to bind cardiolipin in the inner mitochondrial membrane, stabilize mitochondrial structure, and support cellular energy production. Research suggests that SS-31 may reduce mitochondrial oxidative stress by limiting reactive oxygen species accumulation, improving mitochondrial bioenergetics, and supporting membrane integrity. It has also been investigated for its ability to modulate the mitochondrial permeability transition pore (mPTP), potentially reducing apoptosis-related signaling under stress. Due to these mechanisms, SS-31 has attracted attention in research involving neurodegenerative diseases, cardiovascular disorders, age-related mitochondrial decline, and retinal diseases such as diabetic retinopathy and age-related macular degeneration. FRESHLY PREPARED SOLUTION 

Made to Order Compound ✦ Price on Request. Contact us The STAT3 Inhibitor Peptide has been explored in experimental and preclinical research for its potential relevance across multiple cancer-related models, including: Multiple Myeloma Leukemia Glioblastoma Breast and Lung Cancers By selectively interacting with STAT3-associated signaling pathways, this peptide has been investigated for its ability to modulate cellular survival mechanisms and related biological processes, while being evaluated for its differential effects between transformed and non-transformed cells under controlled research conditions.

The STAT3 Inhibitor Peptide has been explored in experimental and preclinical research for its potential relevance across multiple cancer-related models, including: Multiple Myeloma Leukemia Glioblastoma Breast and Lung Cancers By selectively interacting with STAT3-associated signaling pathways, this peptide has been investigated for its ability to modulate cellular survival mechanisms and related biological processes, while being evaluated for its differential effects between transformed and non-transformed cells under controlled research conditions.

Taltirelin is a synthetic TRH analogue studied primarily for its effects in spinocerebellar degeneration and related motor coordination disorders. Acting as a biased superagonist at TRH-R1, it influences central neurotransmission and has been investigated for neuroprotective, anti-ataxic, and pro-cognitive effects. Research suggests taltirelin may modulate multiple neurotransmitter systems, including acetylcholine, dopamine, serotonin, and noradrenaline, contributing to interest in its potential relevance for memory impairment, depressive-like conditions, arousal regulation, and fatigue-related disorders. Additional studies have explored its antinociceptive properties and possible effects on neurite outgrowth and spinal cord-related neural recovery, making it a notable peptide in experimental research involving neurodegeneration, cognition, and neurological resilience.

Taltirelin is a synthetic TRH analogue studied primarily for its effects in spinocerebellar degeneration and related motor coordination disorders. Acting as a biased superagonist at TRH-R1, it influences central neurotransmission and has been investigated for neuroprotective, anti-ataxic, and pro-cognitive effects. Research suggests taltirelin may modulate multiple neurotransmitter systems, including acetylcholine, dopamine, serotonin, and noradrenaline, contributing to interest in its potential relevance for memory impairment, depressive-like conditions, arousal regulation, and fatigue-related disorders. Additional studies have explored its antinociceptive properties and possible effects on neurite outgrowth and spinal cord-related neural recovery, making it a notable peptide in experimental research involving neurodegeneration, cognition, and neurological resilience. FRESHLY PREPARED SOLUTION

TAT-CBD3 is a cell-penetrating peptide designed to modulate neuropathic pain by selectively disrupting the interaction between CRMP-2 and CaV2.2 voltage-gated calcium channels. By reducing calcium influx and excitatory neurotransmitter release, it decreases nociceptor hyperexcitability and abnormal pain signaling. Unlike conventional analgesics, TAT-CBD3 targets upstream molecular mechanisms involved in pain transmission, offering a more selective neuromodulatory approach. Preclinical studies have demonstrated its ability to reduce key features of neuropathic pain, including allodynia, hyperalgesia, and hypersensitivity.

Tesamorelin is a synthetic Growth Hormone-Releasing Hormone (GHRH) analogue designed for improved stability and extended activity in human plasma. By activating pituitary GHRH receptors, it stimulates endogenous growth hormone release while maintaining physiological pulsatile secretion patterns. This leads to increased downstream IGF-1 production, supporting anabolic and metabolic regulation. Research suggests tesamorelin may reduce visceral adipose tissue, support lean muscle maintenance, and influence metabolic health. It has been extensively studied in HIV-associated lipodystrophy, where reductions in abdominal fat have been associated with improved body composition markers and potential improvements in lipid-related cardiovascular risk factors. Emerging research also suggests possible relevance in cognitive aging and neuroendocrine function, as GH and IGF-1 pathways contribute to synaptic plasticity and brain metabolism.

Tesofensine significantly supports weight loss, body fat reduction, and appetite reduction. It increases an individual's resting energy expenditure by stimulating the fat oxidation process. Below are its main effects: - Reduced body fat / Weight loss - Appetite suppression - Improved libido - Better sleep quality - Improved cognitive function

Testagen is a bioregulatory peptide studied for its potential influence on endocrine balance, particularly in relation to thyroid hormone regulation and testosterone-related signaling. It has been described as a peptide capable of penetrating cellular structures and potentially influencing gene regulatory pathways. Research discussions suggest Testagen may support pituitary activity, increasing thyroid-stimulating hormone (TSH) output and indirectly supporting thyroid hormones T3 and T4, contributing to improved metabolism and energy regulation. It has also been explored for potential relevance in testosterone decline research, age-related vitality reduction, and hormonal imbalance-related conditions. Additional research interest includes its possible influence on hemostasis through thyroid-driven pathways and its potential immune-support relevance by modulating cellular differentiation and immune aging mechanisms.

Thymalin is a synthetic peptide bioregulator related to thymic factors such as thymulin, which are involved in immune signaling and the regulation of inflammatory pathways. Research has investigated Thymalin for its potential role in supporting immune function, modulating systemic homeostasis, and influencing age-associated immune decline. Studies suggest that Thymalin may contribute to improved immune resilience, cardiovascular function, and regulation of neuroendocrine processes linked to circadian rhythm and the sleep–wake cycle. It has also attracted significant interest in longevity research, as experimental findings have associated thymic peptide bioregulators with reduced mortality and lifespan extension in animal models.

Thymalin is a synthetic peptide bioregulator related to thymic factors such as thymulin, which are involved in immune signaling and the regulation of inflammatory pathways. Research has investigated Thymalin for its potential role in supporting immune function, modulating systemic homeostasis, and influencing age-associated immune decline. Studies suggest that Thymalin may contribute to improved immune resilience, cardiovascular function, and regulation of neuroendocrine processes linked to circadian rhythm and the sleep–wake cycle. It has also attracted significant interest in longevity research, as experimental findings have associated thymic peptide bioregulators with reduced mortality and lifespan extension in animal models. FRESHLY PREPARED SOLUTION 

Thymosin alpha-1 is a thymus-derived peptide widely studied as a potent regulator of immune function. It supports adaptive immunity by promoting T-cell maturation and enhancing immune communication through cytokine signaling pathways. Research in thymus-deficient models suggests thymosin alpha-1 may restore immune competence and improve resistance to infection. It has also been investigated as a vaccine adjuvant, potentially strengthening immune memory and improving the effectiveness of inactivated vaccines. In addition, thymosin alpha-1 has been studied in sepsis-related research due to its ability to modulate immune responses and potentially improve outcomes in severe infection-driven inflammatory states. These properties make thymosin alpha-1 a peptide of significant interest in research involving immune aging, infection susceptibility, vaccine response, and immune system resilience.

Thymosin Beta-4 Fragment is a short peptide derived from the active region of Thymosin Beta-4, commonly employed in preclinical research to investigate actin-regulated cell migration, angiogenesis, inflammatory modulation, and tissue remodeling mechanisms. In experimental models, it has been studied for its involvement in wound-related cellular dynamics, oxidative stress responses, and regeneration-associated signaling pathways. FRESHLY PREPARED SOLUTION 

INDEPENDENTLY TESTED • VERIFIED QUALITY ✓ Purity — HPLC analysis ✓ Identity — Mass spectrometry ✓ Net content  VERIFY COA AT FREEDOM DIAGNOSTICS → Enter search code: Suaw2605040574Thymosin Beta-4 (Tβ4), often associated with the peptide fragment TB-500 in research contexts, is a naturally occurring peptide involved in tissue repair, immune regulation, and cellular regeneration. Its primary mechanism is linked to actin-binding activity, supporting cytoskeletal remodeling and promoting cell migration essential for wound healing. Research suggests Tβ4 may stimulate angiogenesis, enhance collagen deposition, support keratinocyte and endothelial migration, and reduce inflammatory cytokine signaling through modulation of pathways such as NF-κB. It has been studied in experimental models of skin repair, corneal injury, dry eye conditions, cardiovascular remodeling after ischemic injury, systemic inflammation including sepsis models, neurological injury, autoimmune neuroinflammation, and musculoskeletal recovery. These properties make Tβ4 a major peptide of interest in regenerative biology and inflammation-related research.